The National Eye Institute (NEI) of the National Institutes of Health (NIH) announces the start of a multicenter clinical trial to compare the relative safety and effectiveness of two drugs currently used to treat advanced age-related macular degernation (AMD). The two drugs, Lucentis (ranibizumab) and Avastin (bevacizumab). AMD is a disease that damages the macula.…
Retinopathies may be prevented or lessened by a change in diet. Omega-3 fatty acids protect against the development and progression of retinopathy, a deterioration of the retina, in mice. This is the major finding of a study that appears in the July 2007 issue of the journal Nature Medicine. The study was a collaborative effort by…
His physician-designed, cloud-based system attracts buyers. By Jerry Helzner, Senior Editor Florida-based retina specialist Dan Montzka, MD, 49, has always been something of a “techie.” At the University of Minnesota he was an engineering major. As a fellow at Wills Eye Hospital, he was instrumental in putting instructional material into a CD-ROM format. So it should not…